

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | DNA deamination (GO:0045006) | 4.95813264 |
| 2 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 4.76628564 |
| 3 | cullin deneddylation (GO:0010388) | 4.63482513 |
| 4 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 4.62304147 |
| 5 | chaperone-mediated protein transport (GO:0072321) | 4.35185482 |
| 6 | protein neddylation (GO:0045116) | 4.22973176 |
| 7 | protein deneddylation (GO:0000338) | 4.20854022 |
| 8 | respiratory chain complex IV assembly (GO:0008535) | 4.16782393 |
| 9 | mitochondrial electron transport, NADH to ubiquinone (GO:0006120) | 4.16667239 |
| 10 | energy coupled proton transport, down electrochemical gradient (GO:0015985) | 4.14801250 |
| 11 | ATP synthesis coupled proton transport (GO:0015986) | 4.14801250 |
| 12 | signal peptide processing (GO:0006465) | 4.05699217 |
| 13 | neutrophil activation involved in immune response (GO:0002283) | 4.03847620 |
| 14 | cytochrome complex assembly (GO:0017004) | 3.98192827 |
| 15 | respiratory electron transport chain (GO:0022904) | 3.83515324 |
| 16 | DNA double-strand break processing (GO:0000729) | 3.81216377 |
| 17 | positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051437) | 3.79332750 |
| 18 | electron transport chain (GO:0022900) | 3.76500792 |
| 19 | ribosomal small subunit assembly (GO:0000028) | 3.76287174 |
| 20 | regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051439) | 3.76259811 |
| 21 | negative regulation of ubiquitin-protein transferase activity (GO:0051444) | 3.76036365 |
| 22 | negative regulation of ligase activity (GO:0051352) | 3.76036365 |
| 23 | platelet dense granule organization (GO:0060155) | 3.74012809 |
| 24 | ATP hydrolysis coupled proton transport (GO:0015991) | 3.67198999 |
| 25 | energy coupled proton transmembrane transport, against electrochemical gradient (GO:0015988) | 3.67198999 |
| 26 | rRNA modification (GO:0000154) | 3.66743991 |
| 27 | regulation of mitochondrial translation (GO:0070129) | 3.63849599 |
| 28 | protein targeting to mitochondrion (GO:0006626) | 3.52984771 |
| 29 | mitochondrial respiratory chain complex I assembly (GO:0032981) | 3.47846723 |
| 30 | NADH dehydrogenase complex assembly (GO:0010257) | 3.47846723 |
| 31 | mitochondrial respiratory chain complex I biogenesis (GO:0097031) | 3.47846723 |
| 32 | pseudouridine synthesis (GO:0001522) | 3.36580542 |
| 33 | signal transduction involved in DNA integrity checkpoint (GO:0072401) | 3.35606975 |
| 34 | signal transduction involved in DNA damage checkpoint (GO:0072422) | 3.35606975 |
| 35 | establishment of protein localization to mitochondrion (GO:0072655) | 3.34989422 |
| 36 | signal transduction involved in cell cycle checkpoint (GO:0072395) | 3.34232726 |
| 37 | anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0 | 3.33482780 |
| 38 | water-soluble vitamin biosynthetic process (GO:0042364) | 3.32510817 |
| 39 | protein localization to mitochondrion (GO:0070585) | 3.30551955 |
| 40 | positive regulation of ubiquitin-protein transferase activity (GO:0051443) | 3.25969949 |
| 41 | proteasome assembly (GO:0043248) | 3.20848241 |
| 42 | SRP-dependent cotranslational protein targeting to membrane (GO:0006614) | 3.19281354 |
| 43 | antigen processing and presentation of exogenous peptide antigen via MHC class I (GO:0042590) | 3.19177630 |
| 44 | positive regulation of ligase activity (GO:0051351) | 3.17963848 |
| 45 | lactate metabolic process (GO:0006089) | 3.17083563 |
| 46 | spliceosomal snRNP assembly (GO:0000387) | 3.15338648 |
| 47 | rRNA methylation (GO:0031167) | 3.12640163 |
| 48 | telomere maintenance via semi-conservative replication (GO:0032201) | 3.10562989 |
| 49 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO: | 3.10220697 |
| 50 | protein targeting to ER (GO:0045047) | 3.09704415 |
| 51 | cotranslational protein targeting to membrane (GO:0006613) | 3.08795407 |
| 52 | oxidative phosphorylation (GO:0006119) | 3.08578132 |
| 53 | RNA splicing, via endonucleolytic cleavage and ligation (GO:0000394) | 3.03863846 |
| 54 | tRNA splicing, via endonucleolytic cleavage and ligation (GO:0006388) | 3.03863846 |
| 55 | ribosomal large subunit biogenesis (GO:0042273) | 3.01619157 |
| 56 | protein localization to endoplasmic reticulum (GO:0070972) | 3.00472669 |
| 57 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 2.99851981 |
| 58 | C-terminal protein lipidation (GO:0006501) | 2.99481467 |
| 59 | folic acid-containing compound biosynthetic process (GO:0009396) | 2.99103407 |
| 60 | maturation of 5.8S rRNA (GO:0000460) | 2.98294065 |
| 61 | hydrogen ion transmembrane transport (GO:1902600) | 2.97752533 |
| 62 | positive regulation of gamma-delta T cell activation (GO:0046645) | 2.96209920 |
| 63 | regulation of ubiquitin-protein transferase activity (GO:0051438) | 2.94727834 |
| 64 | maturation of SSU-rRNA (GO:0030490) | 2.93794935 |
| 65 | DNA catabolic process, exonucleolytic (GO:0000738) | 2.92690309 |
| 66 | regulation of B cell receptor signaling pathway (GO:0050855) | 2.92478134 |
| 67 | telomere maintenance via recombination (GO:0000722) | 2.91137690 |
| 68 | oligosaccharide catabolic process (GO:0009313) | 2.90542751 |
| 69 | establishment of protein localization to endoplasmic reticulum (GO:0072599) | 2.90489440 |
| 70 | viral transcription (GO:0019083) | 2.89759494 |
| 71 | translational termination (GO:0006415) | 2.89455994 |
| 72 | regulation of ligase activity (GO:0051340) | 2.89378820 |
| 73 | respiratory burst (GO:0045730) | 2.88104285 |
| 74 | purine deoxyribonucleotide catabolic process (GO:0009155) | 2.86247975 |
| 75 | immunoglobulin mediated immune response (GO:0016064) | 2.85056562 |
| 76 | antigen processing and presentation of peptide antigen via MHC class I (GO:0002474) | 2.84447098 |
| 77 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 2.83778546 |
| 78 | CENP-A containing nucleosome assembly (GO:0034080) | 2.82556696 |
| 79 | chromatin remodeling at centromere (GO:0031055) | 2.82275156 |
| 80 | GTP biosynthetic process (GO:0006183) | 2.81972887 |
| 81 | termination of RNA polymerase III transcription (GO:0006386) | 2.81937365 |
| 82 | transcription elongation from RNA polymerase III promoter (GO:0006385) | 2.81937365 |
| 83 | mannosylation (GO:0097502) | 2.81831960 |
| 84 | regulation of cellular amine metabolic process (GO:0033238) | 2.81521643 |
| 85 | negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class | 2.81107850 |
| 86 | inositol phosphate dephosphorylation (GO:0046855) | 2.79822922 |
| 87 | phosphorylated carbohydrate dephosphorylation (GO:0046838) | 2.79822922 |
| 88 | DNA strand elongation involved in DNA replication (GO:0006271) | 2.79566318 |
| 89 | proton transport (GO:0015992) | 2.79159974 |
| 90 | inositol phosphate catabolic process (GO:0071545) | 2.78817781 |
| 91 | purine nucleotide salvage (GO:0032261) | 2.77433993 |
| 92 | C-terminal protein amino acid modification (GO:0018410) | 2.75802804 |
| 93 | negative regulation of protein ubiquitination (GO:0031397) | 2.74686029 |
| 94 | endosome to melanosome transport (GO:0035646) | 2.73934801 |
| 95 | endosome to pigment granule transport (GO:0043485) | 2.73934801 |
| 96 | hydrogen transport (GO:0006818) | 2.72947769 |
| 97 | deoxyribonucleoside monophosphate metabolic process (GO:0009162) | 2.72233434 |
| 98 | phagosome maturation (GO:0090382) | 2.72001568 |
| 99 | purine nucleoside triphosphate biosynthetic process (GO:0009145) | 2.71790649 |
| 100 | DNA damage response, signal transduction by p53 class mediator (GO:0030330) | 2.68360531 |
| 101 | L-methionine biosynthetic process from methylthioadenosine (GO:0019509) | 2.68297957 |
| 102 | deoxyribonucleoside triphosphate metabolic process (GO:0009200) | 2.66639280 |
| 103 | purine ribonucleoside triphosphate biosynthetic process (GO:0009206) | 2.66485552 |
| 104 | dolichol-linked oligosaccharide biosynthetic process (GO:0006488) | 2.64440955 |
| 105 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 2.63255482 |
| 106 | mitochondrial transport (GO:0006839) | 2.63227988 |
| 107 | inner mitochondrial membrane organization (GO:0007007) | 2.62524708 |
| 108 | positive regulation of cell cycle arrest (GO:0071158) | 2.62323824 |
| 109 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 2.62314074 |
| 110 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 2.62314074 |
| 111 | DNA replication checkpoint (GO:0000076) | 2.62221429 |
| 112 | DNA strand elongation (GO:0022616) | 2.62128203 |
| 113 | purine deoxyribonucleoside triphosphate metabolic process (GO:0009215) | 2.61784863 |
| 114 | interferon-gamma production (GO:0032609) | 2.61704239 |
| 115 | ATP biosynthetic process (GO:0006754) | 2.61594814 |
| 116 | translation (GO:0006412) | 2.61067245 |
| 117 | membrane lipid catabolic process (GO:0046466) | 2.60729325 |
| 118 | negative regulation of protein modification by small protein conjugation or removal (GO:1903321) | 2.60434201 |
| 119 | ribonucleoprotein complex biogenesis (GO:0022613) | 2.60261751 |
| 120 | sphingolipid catabolic process (GO:0030149) | 2.59578661 |
| 121 | nucleobase-containing small molecule interconversion (GO:0015949) | 2.59128614 |
| 122 | pteridine-containing compound biosynthetic process (GO:0042559) | 2.57591006 |
| 123 | translational elongation (GO:0006414) | 2.57013219 |
| 124 | purine nucleobase biosynthetic process (GO:0009113) | 2.55768764 |
| 125 | establishment of protein localization to mitochondrial membrane (GO:0090151) | 2.55740579 |
| 126 | response to peptidoglycan (GO:0032494) | 2.54612191 |
| 127 | B cell mediated immunity (GO:0019724) | 2.54181278 |
| 128 | exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay | 2.53939244 |
| 129 | translational initiation (GO:0006413) | 2.53130643 |
| 130 | peptidyl-histidine modification (GO:0018202) | 2.52563494 |
| 131 | protein complex biogenesis (GO:0070271) | 2.51274969 |
| 132 | ribosome biogenesis (GO:0042254) | 2.51232968 |
| 133 | regulation of RIG-I signaling pathway (GO:0039535) | 2.50619051 |
| 134 | rRNA processing (GO:0006364) | 2.50367482 |
| 135 | ribosomal small subunit biogenesis (GO:0042274) | 2.47590868 |
| 136 | negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051436) | 2.46481892 |
| 137 | mitotic recombination (GO:0006312) | 2.46419661 |
| 138 | nuclear-transcribed mRNA catabolic process, exonucleolytic (GO:0000291) | 2.43065593 |
| 139 | ribosome assembly (GO:0042255) | 2.42726789 |
| 140 | cellular response to interferon-beta (GO:0035458) | 2.42591690 |
| 141 | positive regulation of interferon-alpha production (GO:0032727) | 2.42397089 |
| 142 | regulation of B cell differentiation (GO:0045577) | 2.42369290 |
| 143 | rRNA metabolic process (GO:0016072) | 2.41216163 |
| 144 | deoxyribonucleotide catabolic process (GO:0009264) | 2.40252697 |
| 145 | leukocyte aggregation (GO:0070486) | 2.39670850 |
| 146 | neutrophil activation (GO:0042119) | 2.39334797 |
| 147 | positive regulation of B cell differentiation (GO:0045579) | 2.38646100 |
| 148 | actin nucleation (GO:0045010) | 2.38556618 |
| 149 | viral life cycle (GO:0019058) | 2.37771740 |
| 150 | nucleobase biosynthetic process (GO:0046112) | 2.37395725 |
| 151 | defense response to protozoan (GO:0042832) | 2.37348068 |
| 152 | regulation of cellular amino acid metabolic process (GO:0006521) | 2.37209811 |
| 153 | reactive oxygen species biosynthetic process (GO:1903409) | 2.36691001 |
| 154 | positive regulation of macrophage differentiation (GO:0045651) | 2.36383580 |
| 155 | hydrogen peroxide biosynthetic process (GO:0050665) | 2.35854783 |
| 156 | granulocyte activation (GO:0036230) | 2.35646033 |
| 157 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:00 | 2.35498807 |
| 158 | deoxyribose phosphate biosynthetic process (GO:0046385) | 2.34340029 |
| 159 | 2-deoxyribonucleotide biosynthetic process (GO:0009265) | 2.34340029 |
| 160 | mitochondrial respiratory chain complex assembly (GO:0033108) | 2.34271650 |
| 161 | response to protozoan (GO:0001562) | 2.34133609 |
| 162 | formation of translation preinitiation complex (GO:0001731) | 2.34091370 |
| 163 | chaperone mediated protein folding requiring cofactor (GO:0051085) | 2.33352313 |
| 164 | negative regulation of myeloid cell apoptotic process (GO:0033033) | 2.32998420 |
| 165 | glycosphingolipid catabolic process (GO:0046479) | 2.31985493 |
| 166 | signal transduction involved in mitotic G1 DNA damage checkpoint (GO:0072431) | 2.31581570 |
| 167 | intracellular signal transduction involved in G1 DNA damage checkpoint (GO:1902400) | 2.31581570 |
| 168 | cellular component biogenesis (GO:0044085) | 2.31121434 |
| 169 | signal transduction involved in mitotic cell cycle checkpoint (GO:0072413) | 2.31087453 |
| 170 | signal transduction involved in mitotic DNA integrity checkpoint (GO:1902403) | 2.31087453 |
| 171 | signal transduction involved in mitotic DNA damage checkpoint (GO:1902402) | 2.31087453 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | E2F7_22180533_ChIP-Seq_HELA_Human | 5.16192570 |
| 2 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 3.31888327 |
| 3 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 3.29156236 |
| 4 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 3.27419144 |
| 5 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 3.24561775 |
| 6 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 3.22994057 |
| 7 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 3.21575880 |
| 8 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 2.93923873 |
| 9 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 2.87375766 |
| 10 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 2.79891732 |
| 11 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 2.75429960 |
| 12 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 2.63385409 |
| 13 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 2.56994975 |
| 14 | VDR_23849224_ChIP-Seq_CD4+_Human | 2.52902188 |
| 15 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 2.51280832 |
| 16 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 2.44448868 |
| 17 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.43445795 |
| 18 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 2.42501611 |
| 19 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.38228824 |
| 20 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 2.27246245 |
| 21 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.26562482 |
| 22 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 2.24485891 |
| 23 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 2.20818040 |
| 24 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 2.20694552 |
| 25 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.16876160 |
| 26 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.15329785 |
| 27 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 2.14260484 |
| 28 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 2.12720889 |
| 29 | * FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 2.09806755 |
| 30 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 2.08404449 |
| 31 | DCP1A_22483619_ChIP-Seq_HELA_Human | 2.08348198 |
| 32 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 2.03229821 |
| 33 | ELK1_19687146_ChIP-ChIP_HELA_Human | 2.01990206 |
| 34 | SPI1_23547873_ChIP-Seq_NB4_Human | 2.01367043 |
| 35 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.96073398 |
| 36 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 1.94733755 |
| 37 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.94448219 |
| 38 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.93208566 |
| 39 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.90803434 |
| 40 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 1.90705237 |
| 41 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.90177721 |
| 42 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.83752120 |
| 43 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 1.82331953 |
| 44 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 1.81291520 |
| 45 | GABP_19822575_ChIP-Seq_HepG2_Human | 1.80599544 |
| 46 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.79716842 |
| 47 | E2F1_18555785_ChIP-Seq_MESCs_Mouse | 1.78675986 |
| 48 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 1.76361885 |
| 49 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 1.72705231 |
| 50 | TTF2_22483619_ChIP-Seq_HELA_Human | 1.68452193 |
| 51 | XRN2_22483619_ChIP-Seq_HELA_Human | 1.68238975 |
| 52 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.63847957 |
| 53 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.62122938 |
| 54 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 1.61719464 |
| 55 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 1.61223852 |
| 56 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.57822370 |
| 57 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.57283127 |
| 58 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.55078763 |
| 59 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.50217822 |
| 60 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.49515830 |
| 61 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.47554354 |
| 62 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 1.47512459 |
| 63 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.46980938 |
| 64 | MYC_18940864_ChIP-ChIP_HL60_Human | 1.44718090 |
| 65 | MYB_26560356_Chip-Seq_TH2_Human | 1.40573209 |
| 66 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 1.39490279 |
| 67 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 1.35798625 |
| 68 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 1.34551255 |
| 69 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 1.33335691 |
| 70 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.32984337 |
| 71 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.32420214 |
| 72 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.32347444 |
| 73 | MYC_22102868_ChIP-Seq_BL_Human | 1.31919840 |
| 74 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.30091311 |
| 75 | ZFX_18555785_ChIP-Seq_MESCs_Mouse | 1.29855415 |
| 76 | MYB_26560356_Chip-Seq_TH1_Human | 1.28263287 |
| 77 | MYCN_18555785_ChIP-Seq_MESCs_Mouse | 1.28001812 |
| 78 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.27933980 |
| 79 | VDR_22108803_ChIP-Seq_LS180_Human | 1.27443443 |
| 80 | ELK1_22589737_ChIP-Seq_MCF10A_Human | 1.26174363 |
| 81 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.23255394 |
| 82 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.22511200 |
| 83 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.22247933 |
| 84 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 1.20862292 |
| 85 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.20006970 |
| 86 | POU5F1_18555785_ChIP-Seq_MESCs_Mouse | 1.18559905 |
| 87 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.16720266 |
| 88 | POU5F1_18358816_ChIP-ChIP_MESCs_Mouse | 1.16258921 |
| 89 | ASH2L_23239880_ChIP-Seq_MESCs_Mouse | 1.15788768 |
| 90 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 1.15772051 |
| 91 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.15215941 |
| 92 | CUX1_19635798_ChIP-ChIP_MULTIPLE_HUMAN_CANCER_TYPES_Human | 1.14374360 |
| 93 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.14065590 |
| 94 | PRDM5_23873026_ChIP-Seq_MEFs_Mouse | 1.11540793 |
| 95 | GATA1_22025678_ChIP-Seq_K562_Human | 1.11195594 |
| 96 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.10506297 |
| 97 | MAF_26560356_Chip-Seq_TH1_Human | 1.09693581 |
| 98 | DMRT1_21621532_ChIP-ChIP_FETAL_Ovary | 1.06489163 |
| 99 | KDM5A_27292631_Chip-Seq_BREAST_Human | 1.06066995 |
| 100 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.04461171 |
| 101 | FLI1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.04449587 |
| 102 | UTX_26944678_Chip-Seq_JUKART_Human | 1.03967582 |
| 103 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.03778152 |
| 104 | E2F4_21247883_ChIP-Seq_LYMPHOBLASTOID_Human | 1.03298631 |
| 105 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.02907526 |
| 106 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.01155294 |
| 107 | PADI4_21655091_ChIP-ChIP_MCF-7_Human | 0.98533052 |
| 108 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 0.98504768 |
| 109 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 0.98431840 |
| 110 | MYBL2_22936984_ChIP-ChIP_MESCs_Mouse | 0.98059397 |
| 111 | ELF5_23300383_ChIP-Seq_T47D_Human | 0.96146908 |
| 112 | RCOR1_19997604_ChIP-ChIP_NEURONS_Mouse | 0.94457073 |
| 113 | YY1_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 0.93956965 |
| 114 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.93045583 |
| 115 | ZFP42_18358816_ChIP-ChIP_MESCs_Mouse | 0.92493556 |
| 116 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.91637893 |
| 117 | EWS_26573619_Chip-Seq_HEK293_Human | 0.91183159 |
| 118 | HTT_18923047_ChIP-ChIP_STHdh_Human | 0.87295775 |
| 119 | TP53_22573176_ChIP-Seq_HFKS_Human | 0.84308737 |
| 120 | GRHL2_25758223_ChIP-Seq_PLACENTA_Mouse | 0.82467912 |
| 121 | NANOG_18555785_ChIP-Seq_MESCs_Mouse | 0.82289246 |
| 122 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 0.78807378 |
| 123 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.77506122 |
| 124 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 0.76353952 |
| 125 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 0.74912546 |
| 126 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 0.74815087 |
| 127 | NANOG_18358816_ChIP-ChIP_MESCs_Mouse | 0.73905062 |
| 128 | SOX17_20123909_ChIP-Seq_XEN_Mouse | 0.73314558 |
| 129 | PAX6_23342162_ChIP-ChIP_BETA-FORBRAIN-LENS_Mouse | 0.73292090 |
| 130 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 0.72822237 |
| 131 | NANOG_16153702_ChIP-ChIP_HESCs_Human | 0.72297414 |
| 132 | FUS_26573619_Chip-Seq_HEK293_Human | 0.71814774 |
| 133 | KDM5B_21448134_ChIP-Seq_MESCs_Mouse | 0.71515799 |
| 134 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 0.71384014 |
| 135 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 0.70973748 |
| 136 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 0.70107553 |
| 137 | AR_20517297_ChIP-Seq_VCAP_Human | 0.69702783 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002837_dystrophic_cardiac_calcinosis | 3.52997465 |
| 2 | MP0001835_abnormal_antigen_presentation | 3.49135558 |
| 3 | MP0003693_abnormal_embryo_hatching | 2.99590340 |
| 4 | MP0005671_abnormal_response_to | 2.90605231 |
| 5 | MP0003724_increased_susceptibility_to | 2.89614658 |
| 6 | MP0009785_altered_susceptibility_to | 2.77899226 |
| 7 | MP0003436_decreased_susceptibility_to | 2.70714000 |
| 8 | MP0002139_abnormal_hepatobiliary_system | 2.69604695 |
| 9 | MP0005000_abnormal_immune_tolerance | 2.58697395 |
| 10 | MP0002102_abnormal_ear_morphology | 2.56437657 |
| 11 | MP0003763_abnormal_thymus_physiology | 2.42417904 |
| 12 | MP0005379_endocrine/exocrine_gland_phen | 2.37350255 |
| 13 | MP0002396_abnormal_hematopoietic_system | 2.36009632 |
| 14 | MP0002090_abnormal_vision | 2.35882411 |
| 15 | MP0009333_abnormal_splenocyte_physiolog | 2.35509068 |
| 16 | MP0002419_abnormal_innate_immunity | 2.33696125 |
| 17 | MP0005075_abnormal_melanosome_morpholog | 2.33302693 |
| 18 | MP0002148_abnormal_hypersensitivity_rea | 2.29711413 |
| 19 | MP0002452_abnormal_antigen_presenting | 2.28174859 |
| 20 | MP0005025_abnormal_response_to | 2.22867375 |
| 21 | MP0002723_abnormal_immune_serum | 2.19586277 |
| 22 | MP0005387_immune_system_phenotype | 2.14315408 |
| 23 | MP0001790_abnormal_immune_system | 2.14315408 |
| 24 | MP0002420_abnormal_adaptive_immunity | 2.13313791 |
| 25 | MP0001800_abnormal_humoral_immune | 2.12923061 |
| 26 | MP0005408_hypopigmentation | 2.12100472 |
| 27 | MP0001819_abnormal_immune_cell | 2.11125318 |
| 28 | MP0010234_abnormal_vibrissa_follicle | 2.03316405 |
| 29 | MP0005058_abnormal_lysosome_morphology | 2.01399244 |
| 30 | MP0001853_heart_inflammation | 2.00115269 |
| 31 | MP0002254_reproductive_system_inflammat | 1.99396660 |
| 32 | MP0002398_abnormal_bone_marrow | 1.95633410 |
| 33 | MP0006072_abnormal_retinal_apoptosis | 1.95079042 |
| 34 | MP0003303_peritoneal_inflammation | 1.93370849 |
| 35 | MP0002877_abnormal_melanocyte_morpholog | 1.92525345 |
| 36 | MP0004957_abnormal_blastocyst_morpholog | 1.91393965 |
| 37 | MP0008057_abnormal_DNA_replication | 1.89433379 |
| 38 | MP0000490_abnormal_crypts_of | 1.87984258 |
| 39 | MP0001764_abnormal_homeostasis | 1.84536945 |
| 40 | MP0002277_abnormal_respiratory_mucosa | 1.82839112 |
| 41 | MP0003186_abnormal_redox_activity | 1.82314784 |
| 42 | MP0009840_abnormal_foam_cell | 1.81560228 |
| 43 | MP0000685_abnormal_immune_system | 1.80525925 |
| 44 | MP0008007_abnormal_cellular_replicative | 1.79526086 |
| 45 | MP0002933_joint_inflammation | 1.79302919 |
| 46 | MP0000716_abnormal_immune_system | 1.78341647 |
| 47 | MP0000689_abnormal_spleen_morphology | 1.76963464 |
| 48 | MP0006082_CNS_inflammation | 1.74821578 |
| 49 | MP0010094_abnormal_chromosome_stability | 1.71964842 |
| 50 | MP0002722_abnormal_immune_system | 1.70832936 |
| 51 | MP0005253_abnormal_eye_physiology | 1.68846505 |
| 52 | MP0001545_abnormal_hematopoietic_system | 1.68565220 |
| 53 | MP0005397_hematopoietic_system_phenotyp | 1.68565220 |
| 54 | MP0008058_abnormal_DNA_repair | 1.68541754 |
| 55 | MP0006035_abnormal_mitochondrial_morpho | 1.67414015 |
| 56 | MP0002405_respiratory_system_inflammati | 1.67287886 |
| 57 | MP0005464_abnormal_platelet_physiology | 1.65784507 |
| 58 | MP0002166_altered_tumor_susceptibility | 1.64219533 |
| 59 | MP0002006_tumorigenesis | 1.61198381 |
| 60 | MP0003077_abnormal_cell_cycle | 1.60820799 |
| 61 | MP0000858_altered_metastatic_potential | 1.60183096 |
| 62 | MP0001845_abnormal_inflammatory_respons | 1.59404402 |
| 63 | MP0004510_myositis | 1.58501592 |
| 64 | MP0002429_abnormal_blood_cell | 1.58492666 |
| 65 | MP0002638_abnormal_pupillary_reflex | 1.57789888 |
| 66 | MP0002876_abnormal_thyroid_physiology | 1.56698640 |
| 67 | MP0001533_abnormal_skeleton_physiology | 1.55612064 |
| 68 | MP0000371_diluted_coat_color | 1.55458189 |
| 69 | MP0001851_eye_inflammation | 1.53509616 |
| 70 | MP0005174_abnormal_tail_pigmentation | 1.53042080 |
| 71 | MP0004808_abnormal_hematopoietic_stem | 1.51893613 |
| 72 | MP0009379_abnormal_foot_pigmentation | 1.51381278 |
| 73 | MP0003718_maternal_effect | 1.49782858 |
| 74 | MP0005084_abnormal_gallbladder_morpholo | 1.48450287 |
| 75 | MP0002163_abnormal_gland_morphology | 1.48086703 |
| 76 | MP0003011_delayed_dark_adaptation | 1.47485227 |
| 77 | MP0003111_abnormal_nucleus_morphology | 1.43463267 |
| 78 | MP0010155_abnormal_intestine_physiology | 1.42546803 |
| 79 | MP0003656_abnormal_erythrocyte_physiolo | 1.42529939 |
| 80 | MP0005365_abnormal_bile_salt | 1.42069342 |
| 81 | MP0008469_abnormal_protein_level | 1.36933927 |
| 82 | MP0001324_abnormal_eye_pigmentation | 1.36520185 |
| 83 | MP0000703_abnormal_thymus_morphology | 1.35343596 |
| 84 | MP0000015_abnormal_ear_pigmentation | 1.34683416 |
| 85 | MP0002938_white_spotting | 1.34595400 |
| 86 | MP0001529_abnormal_vocalization | 1.31908079 |
| 87 | MP0004019_abnormal_vitamin_homeostasis | 1.31278478 |
| 88 | MP0002132_abnormal_respiratory_system | 1.29499682 |
| 89 | MP0005332_abnormal_amino_acid | 1.25834182 |
| 90 | MP0005647_abnormal_sex_gland | 1.25328312 |
| 91 | MP0000516_abnormal_urinary_system | 1.23776101 |
| 92 | MP0005367_renal/urinary_system_phenotyp | 1.23776101 |
| 93 | MP0003868_abnormal_feces_composition | 1.20448344 |
| 94 | MP0010386_abnormal_urinary_bladder | 1.20207588 |
| 95 | MP0006054_spinal_hemorrhage | 1.19617015 |
| 96 | MP0001727_abnormal_embryo_implantation | 1.16281719 |
| 97 | MP0004147_increased_porphyrin_level | 1.15734947 |
| 98 | MP0003646_muscle_fatigue | 1.14996805 |
| 99 | MP0004947_skin_inflammation | 1.14853178 |
| 100 | MP0001984_abnormal_olfaction | 1.14828330 |
| 101 | MP0006036_abnormal_mitochondrial_physio | 1.13280773 |
| 102 | MP0002909_abnormal_adrenal_gland | 1.10783398 |
| 103 | MP0002998_abnormal_bone_remodeling | 1.10275622 |
| 104 | MP0002095_abnormal_skin_pigmentation | 1.09477258 |
| 105 | MP0009697_abnormal_copulation | 1.08615622 |
| 106 | MP0005310_abnormal_salivary_gland | 1.05566434 |
| 107 | MP0003448_altered_tumor_morphology | 1.05231610 |
| 108 | MP0002019_abnormal_tumor_incidence | 1.04298691 |
| 109 | MP0000343_altered_response_to | 1.03727714 |
| 110 | MP0003172_abnormal_lysosome_physiology | 1.03459211 |
| 111 | MP0000372_irregular_coat_pigmentation | 1.03349683 |
| 112 | MP0008877_abnormal_DNA_methylation | 1.01163916 |
| 113 | MP0003075_altered_response_to | 1.01006199 |
| 114 | MP0002693_abnormal_pancreas_physiology | 1.00927001 |
| 115 | MP0000313_abnormal_cell_death | 0.99843130 |
| 116 | MP0000604_amyloidosis | 0.98801891 |
| 117 | MP0003136_yellow_coat_color | 0.98658579 |
| 118 | MP0003183_abnormal_peptide_metabolism | 0.98587943 |
| 119 | MP0003866_abnormal_defecation | 0.97016516 |
| 120 | MP0003795_abnormal_bone_structure | 0.96968495 |
| 121 | MP0005319_abnormal_enzyme/_coenzyme | 0.95953650 |
| 122 | MP0001542_abnormal_bone_strength | 0.95428580 |
| 123 | MP0000647_abnormal_sebaceous_gland | 0.92150560 |
| 124 | MP0009764_decreased_sensitivity_to | 0.89976840 |
| 125 | MP0003137_abnormal_impulse_conducting | 0.89819803 |
| 126 | MP0008789_abnormal_olfactory_epithelium | 0.88946305 |
| 127 | MP0001873_stomach_inflammation | 0.86714004 |
| 128 | MP0005171_absent_coat_pigmentation | 0.85686025 |
| 129 | MP0003890_abnormal_embryonic-extraembry | 0.84974430 |
| 130 | MP0000465_gastrointestinal_hemorrhage | 0.83988254 |
| 131 | MP0001756_abnormal_urination | 0.83853770 |
| 132 | MP0009046_muscle_twitch | 0.83175347 |
| 133 | MP0003786_premature_aging | 0.82263856 |
| 134 | MP0002751_abnormal_autonomic_nervous | 0.81770965 |
| 135 | MP0005390_skeleton_phenotype | 0.80462335 |
| 136 | MP0000358_abnormal_cell_content/ | 0.80153159 |
| 137 | MP0005248_abnormal_Harderian_gland | 0.80058126 |
| 138 | MP0001348_abnormal_lacrimal_gland | 0.79437560 |
| 139 | MP0003828_pulmonary_edema | 0.78877788 |
| 140 | MP0005636_abnormal_mineral_homeostasis | 0.78874890 |
| 141 | MP0008932_abnormal_embryonic_tissue | 0.78138796 |
| 142 | MP0002229_neurodegeneration | 0.75612299 |
| 143 | MP0003787_abnormal_imprinting | 0.75130170 |
| 144 | MP0005220_abnormal_exocrine_pancreas | 0.74482384 |
| 145 | MP0003806_abnormal_nucleotide_metabolis | 0.73167425 |
| 146 | MP0002736_abnormal_nociception_after | 0.72876244 |
| 147 | MP0009763_increased_sensitivity_to | 0.72773891 |
| 148 | MP0003121_genomic_imprinting | 0.72060323 |
| 149 | MP0005076_abnormal_cell_differentiation | 0.71588420 |
| 150 | MP0003941_abnormal_skin_development | 0.71303643 |
| 151 | MP0003195_calcinosis | 0.70988043 |
| 152 | MP0000350_abnormal_cell_proliferation | 0.69655131 |
| 153 | MP0005167_abnormal_blood-brain_barrier | 0.69426598 |
| 154 | MP0010329_abnormal_lipoprotein_level | 0.68355099 |
| 155 | MP0010307_abnormal_tumor_latency | 0.68352096 |
| 156 | MP0004133_heterotaxia | 0.67902184 |
| 157 | MP0004215_abnormal_myocardial_fiber | 0.66873668 |
| 158 | MP0005551_abnormal_eye_electrophysiolog | 0.66378728 |
| 159 | MP0005451_abnormal_body_composition | 0.63828959 |
| 160 | MP0003191_abnormal_cellular_cholesterol | 0.63222852 |
| 161 | MP0001186_pigmentation_phenotype | 0.63127202 |
| 162 | MP0003123_paternal_imprinting | 0.62106331 |
| 163 | MP0001919_abnormal_reproductive_system | 0.61231600 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Aplastic anemia (HP:0001915) | 5.42773540 |
| 2 | Recurrent abscess formation (HP:0002722) | 4.47675655 |
| 3 | Vacuolated lymphocytes (HP:0001922) | 4.24383601 |
| 4 | Acute encephalopathy (HP:0006846) | 4.14306226 |
| 5 | Progressive macrocephaly (HP:0004481) | 4.13436752 |
| 6 | Recurrent bacterial skin infections (HP:0005406) | 3.84347748 |
| 7 | Abnormality of macrophages (HP:0004311) | 3.70089317 |
| 8 | Eczematoid dermatitis (HP:0000976) | 3.65570957 |
| 9 | Increased hepatocellular lipid droplets (HP:0006565) | 3.58790397 |
| 10 | Abnormality of cells of the erythroid lineage (HP:0012130) | 3.54413179 |
| 11 | Petechiae (HP:0000967) | 3.52802681 |
| 12 | Oral leukoplakia (HP:0002745) | 3.51374454 |
| 13 | Renal Fanconi syndrome (HP:0001994) | 3.45245811 |
| 14 | Abnormal number of erythroid precursors (HP:0012131) | 3.44783138 |
| 15 | Reduced antithrombin III activity (HP:0001976) | 3.38507286 |
| 16 | Type I transferrin isoform profile (HP:0003642) | 3.36750681 |
| 17 | Lipid accumulation in hepatocytes (HP:0006561) | 3.36630395 |
| 18 | Stomatitis (HP:0010280) | 3.11897943 |
| 19 | Abnormal isoelectric focusing of serum transferrin (HP:0003160) | 3.11382989 |
| 20 | Abnormal protein N-linked glycosylation (HP:0012347) | 3.11382989 |
| 21 | Abnormal protein glycosylation (HP:0012346) | 3.11382989 |
| 22 | Abnormal glycosylation (HP:0012345) | 3.11382989 |
| 23 | Elevated erythrocyte sedimentation rate (HP:0003565) | 3.11114072 |
| 24 | Cerebral edema (HP:0002181) | 3.05120077 |
| 25 | IgM deficiency (HP:0002850) | 3.04300168 |
| 26 | Loss of speech (HP:0002371) | 3.01947095 |
| 27 | Hepatocellular necrosis (HP:0001404) | 2.96555836 |
| 28 | Respiratory failure (HP:0002878) | 2.96119076 |
| 29 | Disinhibition (HP:0000734) | 2.94499120 |
| 30 | Mediastinal lymphadenopathy (HP:0100721) | 2.93789548 |
| 31 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.85300646 |
| 32 | Lactic acidosis (HP:0003128) | 2.82119598 |
| 33 | Hepatic necrosis (HP:0002605) | 2.77774008 |
| 34 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 2.66386523 |
| 35 | Increased intramyocellular lipid droplets (HP:0012240) | 2.64582126 |
| 36 | Chronic obstructive pulmonary disease (HP:0006510) | 2.62760773 |
| 37 | Obstructive lung disease (HP:0006536) | 2.62760773 |
| 38 | Myositis (HP:0100614) | 2.62590377 |
| 39 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.61381005 |
| 40 | Recurrent fungal infections (HP:0002841) | 2.59821721 |
| 41 | Poor head control (HP:0002421) | 2.57044304 |
| 42 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 2.55575729 |
| 43 | Rough bone trabeculation (HP:0100670) | 2.52141987 |
| 44 | Pancytopenia (HP:0001876) | 2.49018703 |
| 45 | Birth length less than 3rd percentile (HP:0003561) | 2.48547529 |
| 46 | Recurrent skin infections (HP:0001581) | 2.47891875 |
| 47 | Dysostosis multiplex (HP:0000943) | 2.47155204 |
| 48 | Recurrent bronchitis (HP:0002837) | 2.46541405 |
| 49 | Methylmalonic aciduria (HP:0012120) | 2.46295584 |
| 50 | Muscle abnormality related to mitochondrial dysfunction (HP:0003800) | 2.43928191 |
| 51 | Methylmalonic acidemia (HP:0002912) | 2.43806701 |
| 52 | Recurrent viral infections (HP:0004429) | 2.41420205 |
| 53 | Hypoplasia of the fovea (HP:0007750) | 2.40527965 |
| 54 | Aplasia/Hypoplasia of the fovea (HP:0008060) | 2.40527965 |
| 55 | Premature graying of hair (HP:0002216) | 2.37501761 |
| 56 | Abnormality of renal resorption (HP:0011038) | 2.36975043 |
| 57 | T lymphocytopenia (HP:0005403) | 2.36468258 |
| 58 | Mutism (HP:0002300) | 2.35671586 |
| 59 | Mitochondrial inheritance (HP:0001427) | 2.35617075 |
| 60 | IgG deficiency (HP:0004315) | 2.34834681 |
| 61 | Pulmonary fibrosis (HP:0002206) | 2.33765492 |
| 62 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 2.32961915 |
| 63 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 2.32961915 |
| 64 | Exercise intolerance (HP:0003546) | 2.32269284 |
| 65 | Neoplasm of the adrenal gland (HP:0100631) | 2.29365065 |
| 66 | Thrombocytosis (HP:0001894) | 2.26333653 |
| 67 | Testicular atrophy (HP:0000029) | 2.25593906 |
| 68 | Abnormality of T cells (HP:0002843) | 2.25266852 |
| 69 | Lethargy (HP:0001254) | 2.24503317 |
| 70 | Pallor (HP:0000980) | 2.24288082 |
| 71 | Increased cerebral lipofuscin (HP:0011813) | 2.24202146 |
| 72 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.23760657 |
| 73 | Recurrent cutaneous fungal infections (HP:0011370) | 2.23760657 |
| 74 | Abnormality of T cell number (HP:0011839) | 2.23730723 |
| 75 | Microvesicular hepatic steatosis (HP:0001414) | 2.23174420 |
| 76 | Exertional dyspnea (HP:0002875) | 2.22419296 |
| 77 | Increased serum ferritin (HP:0003281) | 2.20488214 |
| 78 | Abnormality of methionine metabolism (HP:0010901) | 2.19765371 |
| 79 | Lymphoma (HP:0002665) | 2.18578610 |
| 80 | Lymphopenia (HP:0001888) | 2.17776853 |
| 81 | Agnosia (HP:0010524) | 2.17009463 |
| 82 | Increased muscle lipid content (HP:0009058) | 2.15808290 |
| 83 | CNS demyelination (HP:0007305) | 2.13958757 |
| 84 | Hypoglycemic coma (HP:0001325) | 2.13906806 |
| 85 | Abnormality of the fovea (HP:0000493) | 2.13867609 |
| 86 | Multiple enchondromatosis (HP:0005701) | 2.13811633 |
| 87 | Abnormality of T cell physiology (HP:0011840) | 2.10870338 |
| 88 | Optic disc pallor (HP:0000543) | 2.10026113 |
| 89 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 2.09941264 |
| 90 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 2.06991281 |
| 91 | Abnormal spermatogenesis (HP:0008669) | 2.06936039 |
| 92 | Congenital malformation of the right heart (HP:0011723) | 2.06838053 |
| 93 | Double outlet right ventricle (HP:0001719) | 2.06838053 |
| 94 | Abnormality of B cell number (HP:0010975) | 2.06837813 |
| 95 | B lymphocytopenia (HP:0010976) | 2.06837813 |
| 96 | Severe combined immunodeficiency (HP:0004430) | 2.06539664 |
| 97 | Increased CSF lactate (HP:0002490) | 2.03401694 |
| 98 | Reticulocytopenia (HP:0001896) | 2.03275406 |
| 99 | Gingivitis (HP:0000230) | 2.02790183 |
| 100 | Chronic otitis media (HP:0000389) | 2.02039439 |
| 101 | Prolonged neonatal jaundice (HP:0006579) | 2.01557555 |
| 102 | Bone marrow hypocellularity (HP:0005528) | 2.01384379 |
| 103 | Symptomatic seizures (HP:0011145) | 2.00573290 |
| 104 | Albinism (HP:0001022) | 1.99662353 |
| 105 | Aplasia/Hypoplasia of the macula (HP:0008059) | 1.98617568 |
| 106 | Urinary glycosaminoglycan excretion (HP:0003541) | 1.98331628 |
| 107 | Mucopolysacchariduria (HP:0008155) | 1.98331628 |
| 108 | Increased serum lactate (HP:0002151) | 1.97269280 |
| 109 | Tongue fasciculations (HP:0001308) | 1.97147193 |
| 110 | Leukodystrophy (HP:0002415) | 1.96696553 |
| 111 | Abnormality of liposaccharide metabolism (HP:0010968) | 1.96195148 |
| 112 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 1.96195148 |
| 113 | Abnormality of glycolipid metabolism (HP:0010969) | 1.96195148 |
| 114 | Generalized aminoaciduria (HP:0002909) | 1.95838230 |
| 115 | Pustule (HP:0200039) | 1.95766654 |
| 116 | 3-Methylglutaconic aciduria (HP:0003535) | 1.94876825 |
| 117 | Hypokinesia (HP:0002375) | 1.94793884 |
| 118 | Meningitis (HP:0001287) | 1.94712465 |
| 119 | Abnormal trabecular bone morphology (HP:0100671) | 1.94525711 |
| 120 | Respiratory difficulties (HP:0002880) | 1.93918146 |
| 121 | Basal ganglia calcification (HP:0002135) | 1.90288940 |
| 122 | Abnormality of polysaccharide metabolism (HP:0011012) | 1.90134401 |
| 123 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 1.90134401 |
| 124 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 1.90134401 |
| 125 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 1.90133646 |
| 126 | Macrocytic anemia (HP:0001972) | 1.89964305 |
| 127 | Progressive neurologic deterioration (HP:0002344) | 1.89885512 |
| 128 | Orchitis (HP:0100796) | 1.88765550 |
| 129 | Abnormality of the anterior horn cell (HP:0006802) | 1.86932930 |
| 130 | Degeneration of anterior horn cells (HP:0002398) | 1.86932930 |
| 131 | Irregular epiphyses (HP:0010582) | 1.85614271 |
| 132 | Nausea (HP:0002018) | 1.83841203 |
| 133 | Medial flaring of the eyebrow (HP:0010747) | 1.83612052 |
| 134 | Combined immunodeficiency (HP:0005387) | 1.83323529 |
| 135 | Blindness (HP:0000618) | 1.83314088 |
| 136 | Acute necrotizing encephalopathy (HP:0006965) | 1.83276041 |
| 137 | Colon cancer (HP:0003003) | 1.83020574 |
| 138 | Hypoglycemic seizures (HP:0002173) | 1.82855153 |
| 139 | Microretrognathia (HP:0000308) | 1.82641221 |
| 140 | Aplasia/Hypoplasia affecting the retina (HP:0008061) | 1.82185624 |
| 141 | Abnormal mitochondria in muscle tissue (HP:0008316) | 1.81695782 |
| 142 | Hypoplasia of the thymus (HP:0000778) | 1.80690624 |
| 143 | Abnormality of urine glucose concentration (HP:0011016) | 1.80337850 |
| 144 | Glycosuria (HP:0003076) | 1.80337850 |
| 145 | Increased serum pyruvate (HP:0003542) | 1.80192895 |
| 146 | Leukocytosis (HP:0001974) | 1.79154980 |
| 147 | Autoimmune thrombocytopenia (HP:0001973) | 1.78835637 |
| 148 | Prolonged bleeding time (HP:0003010) | 1.78712005 |
| 149 | Abnormality of midbrain morphology (HP:0002418) | 1.78475300 |
| 150 | Molar tooth sign on MRI (HP:0002419) | 1.78475300 |
| 151 | Epistaxis (HP:0000421) | 1.78462565 |
| 152 | Retrobulbar optic neuritis (HP:0100654) | 1.76870950 |
| 153 | Optic neuritis (HP:0100653) | 1.76870950 |
| 154 | Atrophy/Degeneration involving motor neurons (HP:0007373) | 1.76343801 |
| 155 | Cellulitis (HP:0100658) | 1.76099582 |
| 156 | X-linked dominant inheritance (HP:0001423) | 1.74065775 |
| 157 | Prostate neoplasm (HP:0100787) | 1.73189406 |
| 158 | Abnormality of vitamin B metabolism (HP:0004340) | 1.71553518 |
| 159 | Hyperglycinemia (HP:0002154) | 1.70113318 |
| 160 | Decreased electroretinogram (ERG) amplitude (HP:0000654) | 1.68919376 |
| 161 | Congenital nonbullous ichthyosiform erythroderma (HP:0007479) | 1.68016975 |
| 162 | Nuclear cataract (HP:0100018) | 1.67427860 |
| 163 | Hyperinsulinemic hypoglycemia (HP:0000825) | 1.66819734 |
| 164 | Dicarboxylic aciduria (HP:0003215) | 1.66296083 |
| 165 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 1.66296083 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | NME2 | 4.42989648 |
| 2 | VRK2 | 3.45651392 |
| 3 | CDC7 | 2.91816589 |
| 4 | EIF2AK1 | 2.87201340 |
| 5 | EIF2AK3 | 2.74917351 |
| 6 | MAP4K2 | 2.72219250 |
| 7 | WNK3 | 2.66285562 |
| 8 | TRIM28 | 2.49493555 |
| 9 | IRAK4 | 2.44056903 |
| 10 | IRAK3 | 2.42892106 |
| 11 | FRK | 2.41025597 |
| 12 | PIM2 | 2.35472888 |
| 13 | MAP3K12 | 2.23699677 |
| 14 | TXK | 2.23086431 |
| 15 | STK16 | 2.19936307 |
| 16 | NUAK1 | 2.13874273 |
| 17 | BLK | 2.05754426 |
| 18 | MAP3K10 | 2.05073073 |
| 19 | MAP4K1 | 2.00787893 |
| 20 | WEE1 | 1.93884869 |
| 21 | MAP3K14 | 1.86537269 |
| 22 | TBK1 | 1.84247450 |
| 23 | CSNK1G3 | 1.80158252 |
| 24 | SCYL2 | 1.78271266 |
| 25 | PDK2 | 1.78237256 |
| 26 | SRPK1 | 1.77622630 |
| 27 | NEK9 | 1.73942704 |
| 28 | PLK3 | 1.72185971 |
| 29 | CSNK1G1 | 1.68935577 |
| 30 | VRK1 | 1.68687525 |
| 31 | KIT | 1.67119225 |
| 32 | JAK3 | 1.66602335 |
| 33 | ZAP70 | 1.65526941 |
| 34 | BUB1 | 1.64360801 |
| 35 | PBK | 1.62249046 |
| 36 | TEC | 1.60454362 |
| 37 | BRSK2 | 1.58322816 |
| 38 | ACVR1B | 1.57686757 |
| 39 | CSNK1G2 | 1.53264900 |
| 40 | PLK4 | 1.52857049 |
| 41 | KDR | 1.42182241 |
| 42 | ADRBK2 | 1.40375757 |
| 43 | BRAF | 1.39178952 |
| 44 | TLK1 | 1.36071747 |
| 45 | RPS6KA4 | 1.34584409 |
| 46 | CSNK1A1L | 1.34131836 |
| 47 | IKBKB | 1.33447861 |
| 48 | MAP3K11 | 1.33408526 |
| 49 | TYK2 | 1.32257758 |
| 50 | MAP2K2 | 1.30290207 |
| 51 | IKBKE | 1.26405558 |
| 52 | MAP3K4 | 1.25599593 |
| 53 | ERBB3 | 1.24085419 |
| 54 | MARK3 | 1.23116857 |
| 55 | MKNK2 | 1.19105984 |
| 56 | TNIK | 1.16466482 |
| 57 | MST4 | 1.16342347 |
| 58 | DYRK3 | 1.14470748 |
| 59 | LIMK1 | 1.13695525 |
| 60 | MAP3K3 | 1.12851886 |
| 61 | SYK | 1.10933806 |
| 62 | NEK1 | 1.09753373 |
| 63 | CAMKK2 | 1.09293987 |
| 64 | BTK | 1.08893151 |
| 65 | TAF1 | 1.07318544 |
| 66 | NLK | 1.05898848 |
| 67 | TAOK3 | 1.05038155 |
| 68 | RIPK4 | 1.00911175 |
| 69 | MAP2K7 | 0.97597001 |
| 70 | ERN1 | 0.96946797 |
| 71 | TGFBR1 | 0.96650517 |
| 72 | NME1 | 0.94572365 |
| 73 | PIM1 | 0.91390535 |
| 74 | BCR | 0.91294870 |
| 75 | ABL2 | 0.88648770 |
| 76 | DAPK1 | 0.88194866 |
| 77 | PLK2 | 0.88023550 |
| 78 | LYN | 0.87723409 |
| 79 | LCK | 0.86773196 |
| 80 | CDK8 | 0.86506850 |
| 81 | EIF2AK2 | 0.85835173 |
| 82 | CASK | 0.82780391 |
| 83 | DYRK2 | 0.81200567 |
| 84 | TTK | 0.80146861 |
| 85 | PAK4 | 0.78767749 |
| 86 | FLT3 | 0.78593313 |
| 87 | NEK2 | 0.78511571 |
| 88 | MKNK1 | 0.76840310 |
| 89 | TSSK6 | 0.76505776 |
| 90 | BMPR2 | 0.76046089 |
| 91 | ZAK | 0.74932989 |
| 92 | SIK3 | 0.68443763 |
| 93 | GRK1 | 0.66725800 |
| 94 | PLK1 | 0.64315000 |
| 95 | MAP2K3 | 0.63076711 |
| 96 | AURKB | 0.61714917 |
| 97 | FER | 0.61667346 |
| 98 | TGFBR2 | 0.59840623 |
| 99 | ATR | 0.58665334 |
| 100 | FGR | 0.58627124 |
| 101 | JAK1 | 0.57596905 |
| 102 | STK24 | 0.56447337 |
| 103 | PASK | 0.56285109 |
| 104 | ITK | 0.56009386 |
| 105 | PINK1 | 0.55589939 |
| 106 | MATK | 0.54877128 |
| 107 | BCKDK | 0.53848603 |
| 108 | CCNB1 | 0.52410686 |
| 109 | CAMK2D | 0.52099266 |
| 110 | PRKCG | 0.51825971 |
| 111 | TESK2 | 0.50762260 |
| 112 | TAOK1 | 0.50704980 |
| 113 | CDK3 | 0.50277786 |
| 114 | FES | 0.49907086 |
| 115 | HIPK2 | 0.49045164 |
| 116 | STK10 | 0.48960218 |
| 117 | CHEK2 | 0.48672928 |
| 118 | PRKCI | 0.47473206 |
| 119 | LRRK2 | 0.46471208 |
| 120 | TESK1 | 0.46212883 |
| 121 | CHUK | 0.46170801 |
| 122 | CSNK1A1 | 0.44637717 |
| 123 | IRAK1 | 0.44471047 |
| 124 | CSNK2A1 | 0.44257896 |
| 125 | ERBB4 | 0.43769132 |
| 126 | CDK7 | 0.43711463 |
| 127 | GRK6 | 0.43375877 |
| 128 | GRK7 | 0.43227501 |
| 129 | CSK | 0.43117581 |
| 130 | CSF1R | 0.42937177 |
| 131 | RPS6KA5 | 0.41763847 |
| 132 | CDK19 | 0.41176742 |
| 133 | STK38L | 0.41097540 |
| 134 | STK3 | 0.40984142 |
| 135 | PHKG2 | 0.39006471 |
| 136 | PHKG1 | 0.39006471 |
| 137 | CDK6 | 0.38726377 |
| 138 | PRKCE | 0.37228687 |
| 139 | MAP3K8 | 0.37042377 |
| 140 | PRKCD | 0.36945685 |
| 141 | STK4 | 0.36635253 |
| 142 | BMPR1B | 0.36059221 |
| 143 | IRAK2 | 0.34681296 |
| 144 | BRSK1 | 0.34285644 |
| 145 | AURKA | 0.32928937 |
| 146 | CSNK2A2 | 0.32223371 |
| 147 | GSK3A | 0.32129204 |
| 148 | ATM | 0.31996114 |
| 149 | MAP3K5 | 0.31898350 |
| 150 | JAK2 | 0.31770211 |
| 151 | CAMK2G | 0.30470118 |
| 152 | DAPK3 | 0.28980118 |
| 153 | OXSR1 | 0.27841975 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Ribosome_Homo sapiens_hsa03010 | 3.12012573 |
| 2 | DNA replication_Homo sapiens_hsa03030 | 3.11140555 |
| 3 | Proteasome_Homo sapiens_hsa03050 | 3.09142797 |
| 4 | Protein export_Homo sapiens_hsa03060 | 3.03851541 |
| 5 | RNA polymerase_Homo sapiens_hsa03020 | 2.60913649 |
| 6 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 2.48971006 |
| 7 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 2.47164842 |
| 8 | Fatty acid elongation_Homo sapiens_hsa00062 | 2.43570219 |
| 9 | Mismatch repair_Homo sapiens_hsa03430 | 2.22480393 |
| 10 | Homologous recombination_Homo sapiens_hsa03440 | 2.16732106 |
| 11 | Other glycan degradation_Homo sapiens_hsa00511 | 2.10352023 |
| 12 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 2.00938929 |
| 13 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 2.00539054 |
| 14 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 2.00177384 |
| 15 | Base excision repair_Homo sapiens_hsa03410 | 1.90289375 |
| 16 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 1.87113678 |
| 17 | Spliceosome_Homo sapiens_hsa03040 | 1.85160671 |
| 18 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.78049061 |
| 19 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.74694674 |
| 20 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 1.71905218 |
| 21 | Leishmaniasis_Homo sapiens_hsa05140 | 1.70632380 |
| 22 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.66481493 |
| 23 | Nucleotide excision repair_Homo sapiens_hsa03420 | 1.64562265 |
| 24 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.59766341 |
| 25 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.58236881 |
| 26 | RNA degradation_Homo sapiens_hsa03018 | 1.56650949 |
| 27 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.55851399 |
| 28 | Legionellosis_Homo sapiens_hsa05134 | 1.53679812 |
| 29 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 1.52600450 |
| 30 | Lysosome_Homo sapiens_hsa04142 | 1.48772587 |
| 31 | Glutathione metabolism_Homo sapiens_hsa00480 | 1.47511823 |
| 32 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 1.43333367 |
| 33 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.40612657 |
| 34 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 1.37003727 |
| 35 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.35216408 |
| 36 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.34924006 |
| 37 | RNA transport_Homo sapiens_hsa03013 | 1.34255818 |
| 38 | Basal transcription factors_Homo sapiens_hsa03022 | 1.33586118 |
| 39 | Parkinsons disease_Homo sapiens_hsa05012 | 1.31581369 |
| 40 | Measles_Homo sapiens_hsa05162 | 1.31086830 |
| 41 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.30782816 |
| 42 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.29725904 |
| 43 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.28797170 |
| 44 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.27232689 |
| 45 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.23139908 |
| 46 | Tuberculosis_Homo sapiens_hsa05152 | 1.23031743 |
| 47 | Non-homologous end-joining_Homo sapiens_hsa03450 | 1.20177460 |
| 48 | Purine metabolism_Homo sapiens_hsa00230 | 1.19459190 |
| 49 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.16754319 |
| 50 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 1.14497121 |
| 51 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.14020762 |
| 52 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.13599818 |
| 53 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.11494361 |
| 54 | One carbon pool by folate_Homo sapiens_hsa00670 | 1.10856251 |
| 55 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.09093846 |
| 56 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 1.08738112 |
| 57 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.07914310 |
| 58 | Apoptosis_Homo sapiens_hsa04210 | 1.07224554 |
| 59 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.06349051 |
| 60 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 1.05618350 |
| 61 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.05443855 |
| 62 | Cell cycle_Homo sapiens_hsa04110 | 1.04827183 |
| 63 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 1.04787514 |
| 64 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 1.04030268 |
| 65 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.03802909 |
| 66 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.03293573 |
| 67 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 1.03149170 |
| 68 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.03012114 |
| 69 | Galactose metabolism_Homo sapiens_hsa00052 | 1.02093388 |
| 70 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.99997738 |
| 71 | Huntingtons disease_Homo sapiens_hsa05016 | 0.98497888 |
| 72 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.97377621 |
| 73 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.97109318 |
| 74 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.96186829 |
| 75 | Peroxisome_Homo sapiens_hsa04146 | 0.95224316 |
| 76 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.94819328 |
| 77 | Asthma_Homo sapiens_hsa05310 | 0.94608078 |
| 78 | Phagosome_Homo sapiens_hsa04145 | 0.93613006 |
| 79 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.92974882 |
| 80 | Pertussis_Homo sapiens_hsa05133 | 0.91345701 |
| 81 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.91274987 |
| 82 | Allograft rejection_Homo sapiens_hsa05330 | 0.87670043 |
| 83 | Metabolic pathways_Homo sapiens_hsa01100 | 0.86022230 |
| 84 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.84158376 |
| 85 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.83808781 |
| 86 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.83574637 |
| 87 | Shigellosis_Homo sapiens_hsa05131 | 0.82578565 |
| 88 | Influenza A_Homo sapiens_hsa05164 | 0.81894367 |
| 89 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.81751642 |
| 90 | Hepatitis B_Homo sapiens_hsa05161 | 0.81641554 |
| 91 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.81485719 |
| 92 | Malaria_Homo sapiens_hsa05144 | 0.80075471 |
| 93 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.78501756 |
| 94 | Carbon metabolism_Homo sapiens_hsa01200 | 0.77292098 |
| 95 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.76769588 |
| 96 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.69206479 |
| 97 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.69062839 |
| 98 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.68934467 |
| 99 | Alzheimers disease_Homo sapiens_hsa05010 | 0.68406845 |
| 100 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.66304577 |
| 101 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.65995317 |
| 102 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.65489517 |
| 103 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.63707468 |
| 104 | Sulfur relay system_Homo sapiens_hsa04122 | 0.63521995 |
| 105 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.63157754 |
| 106 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.62579688 |
| 107 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.62409395 |
| 108 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.60837737 |
| 109 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.60547014 |
| 110 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.60093640 |
| 111 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.58157401 |
| 112 | Thyroid cancer_Homo sapiens_hsa05216 | 0.57950130 |
| 113 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.57329656 |
| 114 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.56153654 |
| 115 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.54503466 |
| 116 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.50275746 |
| 117 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 0.49881876 |
| 118 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.48703350 |
| 119 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.47933558 |
| 120 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.47299380 |
| 121 | HTLV-I infection_Homo sapiens_hsa05166 | 0.44819037 |
| 122 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.43400772 |
| 123 | Mineral absorption_Homo sapiens_hsa04978 | 0.41720130 |
| 124 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.39742315 |
| 125 | Salmonella infection_Homo sapiens_hsa05132 | 0.39350815 |
| 126 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.38901525 |
| 127 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.35696861 |
| 128 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.33942624 |
| 129 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.33752426 |
| 130 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 0.33197807 |
| 131 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.32928150 |
| 132 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.32722083 |
| 133 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.32707689 |
| 134 | Phototransduction_Homo sapiens_hsa04744 | 0.31099071 |
| 135 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.31050299 |
| 136 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.30992402 |
| 137 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.28648371 |
| 138 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.26853516 |
| 139 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.26424431 |
| 140 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.25313717 |
| 141 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.24620194 |

